Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Swine Influenza Project to Better Understand Virus Transmission

Published: Friday, December 13, 2013
Last Updated: Friday, December 13, 2013
Bookmark and Share
The Pirbright Institute in Surrey has been awarded £4.4 million to work with researchers from universities on a long-term study on the transmission of swine influenza.

The BBSRC Swine Flu Dynamics project is a five-year project, which as well as researching virus transmission will also assess the effectiveness of different control strategies for the disease to improve animal health and help protect the UK economy.

The University’s School of Veterinary Sciences has one of the world’s leading research groups in pig immunology.  As part of the project Bristol researchers, Mick Bailey, Professor of Comparative Immunology and Dr Ross Harley, Lecturer in Veterinary Pathology, will characterise the immune response to influenza virus in the respiratory tract and blood of vaccinated and infected animals.

Their research will be used to help interpret results from studies of transmission and virus evolution in vaccinated and infected animals, to develop robust epidemiological models.

Dr Bryan Charleston from The Pirbright Institute, who is leading the project, said: “These studies will provide essential evidence to design control programmes for influenza in pigs. We will look at the efficiency of current methods of control, the level of immunity required in a population to prevent the spread, and whether new, broadly cross-protective vaccines are more effective at enhancing animal health and livestock production.”

Swine influenza attracts considerable attention because of the threat of viruses from pigs infecting people. The last pandemic occurred in 2009 and as well as affecting the UK population the outbreak led to trade bans on pork and pig products in some countries and the destruction of animals in others.

Currently vaccination against influenza in pigs is not routinely performed in Europe and the cost benefit of vaccination has not been clearly demonstrated. Furthermore, it is not clear if available vaccines will protect against the strains presently circulating in the pig population.

The collaborative research team aim to better understand the transmission dynamics of the virus, the effectiveness of current vaccines and assess the benefits of different control strategies.

At the present time this type of information is not available for any other mammal that is susceptible to flu viruses, including humans. The results of these studies will therefore not only contribute to improving animal health in pigs but will also have a broader impact on all influenza control measures.

The research grant is part of £17.7 million awarded by the Biotechnology and Biological Sciences Research Council (BBSRC) to fund six major long-term research projects that harness the power of bioscience. The awards are being funded through BBSRC's Strategic Longer and Larger Awards (sLoLas), which give world-leading teams the time and resources to address areas of key strategic importance. The projects were chosen based on their scientific excellence; because they required long timescales, extensive resources and/or multidisciplinary approaches; and they involve internationally leading research teams.

Professor Jackie Hunter, BBSRC’s Chief Executive, said: “This public funding offers long-term support to address major research challenges, while building research capacity in important areas and maximising economic and social benefits for the UK.”

“The vital knowledge generated by this research will help to address the threat of farmed-animal diseases, the health of an ageing population, and the need for more sustainable industries and energy sources.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

What Causes Immune Cell Migration To Wounds
Study shows triggers which lead immune cells to react and respond to wounded sites.
Friday, May 29, 2015
New Findings Could Influence the Development of Therapies to Treat Dengue Disease
New research into the fight against Dengue may influence the development of anti-viral therapies that are effective against all four types of the virus.
Monday, August 05, 2013
Scientists Find Calcium is the Initial Trigger in Our Immune Response to Healing
For the first time scientists studying the cellular processes underlying the body’s response to healing have revealed how a flash of calcium is the very first step in repairing damaged tissue.
Monday, February 18, 2013
Scientists Find Calcium is the Initial Trigger in our Immune Response to Healing
The findings, published in Current Biology, could lead to new therapies that speed up the healing process following injury or surgery.
Thursday, February 14, 2013
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!